ADC Therapeutics S.A. (ADCT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ADC Therapeutics S.A., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.14x | -1.22x | -0.57x | -1.91x | -6.74x | -8.50x |
| P/B Ratio | -2.41x | -0.95x | -0.91x | 3.78x | 9.33x | 6.24x |
| P/S Ratio | 5.51x | 2.73x | 1.95x | 1.43x | 45.71x | 0.00x |
| Profitability | ||||||
| Gross Margin | 90.6% | 91.6% | 96.4% | 98.4% | 95.9% | 0.0% |
| Operating Margin | -133.2% | -184.4% | -238.6% | -58.8% | -771.6% | 0.0% |
| Net Margin | -175.3% | -222.8% | -345.1% | -74.9% | -678.2% | 0.0% |
| EBITDA Margin | -130.9% | -144.9% | -209.6% | -51.3% | -679.7% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 4.37x | 3.82x | 4.97x | 5.31x | 7.10x | 11.14x |
| Quick Ratio | 4.31x | 3.59x | 4.73x | 5.16x | 6.95x | 11.14x |
| Leverage | ||||||
| Debt/Equity | -2.36x | -0.61x | -0.84x | 1.63x | 0.84x | 0.34x |
YoY = year-over-year change. Source: FMP..